Printed on Mon Sep 26 2022 7:40:39 PM

India allowed Covid vaccine export to Bangladesh

International Desk
World
Covid vaccine
India has allowed the export of the coronavirus vaccine to Bangladesh. According to sources in the country's health ministry, the Serum Institute of India (SII) has been allowed to export 1 million doses of Covishield vaccine to Bangladesh.

This information has been known in a report of The Hindu.

Apart from Bangladesh, Delhi has also allowed the export of the Covishield vaccine to Nepal and Myanmar.

The serum will be able to export 1 million doses of the Covishield vaccine in each country. The Pune-based pharmaceutical company has also been allowed to supply 30 million doses of Covishield vaccine to AstraZeneca in the UK.

Meanwhile, India Biotech has been allowed to supply 1 million doses of locally produced COVAX vaccine to Iran.

India Biotech has developed this vaccine. Sources in the Indian Ministry of Health said the vaccine would be delivered to these countries this month under the 'Vaccine Friendship' program.

A senior Indian health ministry official said one million doses of the COVAX vaccine from India Biotech would be sent to Iran in October under the 'Vaccine Friendship' program.

At the same time, 1 million doses of the Covishield vaccine of Serum Institute of India will be provided in Bangladesh, Myanmar, and Nepal.

The official added that AstraZeneca had also been allowed to supply about 30 million doses of the Covishield vaccine this month.

Voice TV/IA
Latest News